Deep Field Asset Management’s BioLife Solutions BLFS Stock Holding History

Deep Field Asset Management’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-80,000	Closed	-$1.43M	–	15
2019 Q1	$1.43M	Sell	80,000 -6,040	-7%	-$96.1K	0.52%	12
2018 Q4	$1.03M	Buy	+86,040	New	+$1.03M	0.96%	12

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

SCM

Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Deep Field Asset Management's BLFS Position: Q2 2019 in Review

Deep Field Asset Management sold out of BioLife Solutions (BLFS) in Q2 2019, closing a stake of 80,000 shares — an estimated $1.43M sold.

Deep Field Asset Management first reported a position in BLFS in Q4 2018 and held it in 2 quarters. The position peaked at $1.43M in Q1 2019. 73 funds tracked by Wall St. Rank hold BLFS as of Q2 2019.

Deep Field Asset Management reported no remaining BioLife Solutions position as of Q2 2019 after selling out during the quarter.
Deep Field Asset Management sold 80,000 BioLife Solutions shares in Q2 2019, an estimated $1.43M.
Deep Field Asset Management first reported a position in BioLife Solutions in Q4 2018 and held it in 2 quarters.
Deep Field Asset Management's BioLife Solutions position peaked at $1.43M in Q1 2019.
73 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2019.

Based on Deep Field Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.